Skip to main content
Premium Trial:

Request an Annual Quote

Deepcell Raises $73M in Series B Funding Round

NEW YORK – Life science company Deepcell raised $73 million in a Series B funding round led by Koch Disruptive Technologies, the company announced on Thursday.

Deepcell intends to use its new funding to advance development and early commercial introduction of its single-cell analysis platform.

"The new funding will help us to accelerate our growth, develop our platform, and take a major step toward full commercialization," Deepcell CEO and Cofounder Maddison Masaeli said in a statement.

Deepcell's platform uses cell imaging, microfluidics, and artificial intelligence to analyze and sort cells based on visual features. The platform is designed to keep cells intact during isolation and analysis, enabling downstream cellular characterization of single cells, with applications including understanding cellular heterogeneity and improved cell subtyping.

Deepcell is exploring the applications of its platform in collaborations, including one with TGen, to characterize the melanoma microenvironment, and with Stanford University, to help build a broad-scale human cell atlas.

Other investors in this funding round included Bridger Healthcare, Horizons Ventures, and Casdin Capital. Returning investors from previous rounds include Andreessen Horowitz and Bow Capital as well as Jeff Dean, head of Google Brain, and Matt Mcllwain, managing director at Madrona Venture Group.

This Series B financing brings Deepcell's overall funding to nearly $100 million since the company's inception in 2017.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.